Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Sci Signal ; 15(724): eabd2533, 2022 03 08.
Article in English | MEDLINE | ID: mdl-35258998

ABSTRACT

The pathogenesis of sepsis-induced acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) has not yet been fully elucidated. Growth arrest-specific 6 (Gas6) has marked effects on hemostasis and reduces inflammation through its interaction with receptor tyrosine kinases of the TAM family: Tyro3, Axl, and Mer. Here, we found that plasma concentrations of Gas6 and soluble Mer were greater in patients with severe sepsis or septic ALI/ARDS compared with those in normal healthy donors. To determine whether the Gas6-Mer axis was critical in the pathogenesis of ALI/ARDS, we investigated the effects of intravenous administration of the selective Mer inhibitor UNC2250 on lipopolysaccharide (LPS)-induced ALI in mouse models subjected to inhalation of LPS. UNC2250 markedly inhibited the infiltration into the lungs of neutrophils and monocytes with increased amounts of Gas6 and Mer proteins, severe lung damage, and increased amounts of reactive oxygen species (ROS) in LPS-induced ALI in mice. In human pulmonary aortic endothelial cells, LPS induced decreases in the amounts of endothelial nitric oxide synthase, thrombomodulin, and vascular endothelial-cadherin, which was blocked by treatment with UNC2250. UNC2250 also inhibited the LPS-dependent increases in cell proliferation and enhanced apoptosis in HL-60 cells, a human neutrophil-like cell line, and RAW264.7 cells, a mouse monocyte/macrophage cell line. These data provide insights into the potential multiple beneficial effects of the Mer inhibitor UNC2250 as a therapeutic reagent to treat inflammatory responses in ALI/ARDS.


Subject(s)
Respiratory Distress Syndrome , Sepsis , Animals , Endothelial Cells/metabolism , Humans , Lipopolysaccharides/pharmacology , Lung/metabolism , Mice , Mice, Inbred C57BL , Respiratory Distress Syndrome/chemically induced , Respiratory Distress Syndrome/drug therapy , Sepsis/metabolism
2.
Neurochem Int ; 150: 105179, 2021 11.
Article in English | MEDLINE | ID: mdl-34500023

ABSTRACT

Schizophrenia is a major psychiatric disorder, but the molecular mechanisms leading to its initiation or progression remain unclear. To elucidate the pathophysiology of schizophrenia, we used an in vitro neuronal cell culture model involving human induced pluripotent stem cells (hiPSCs) derived from a monozygotic-twin discordant schizophrenia pair. The cultured neurons differentiated from hiPSCs were composed of a mixture of glutamatergic excitatory neurons and gamma aminobutyric acid (GABA)ergic inhibitory neurons. In the electrophysiological analysis, a different pattern of spontaneous neuronal activity was observed under the condition without any stimulants. The frequency of spontaneous excitatory post-synaptic currents (sEPSCs) was significantly higher in the hiPSC-derived neurons of the patient with schizophrenia than in the control sibling at day-in-vitro 30. However, the synaptic formation was not different between the patient with schizophrenia and the control sibling during the same culture period. To explain underlying mechanisms of higher excitability of presynaptic cells, we focused on the potassium-chloride co-transporter KCC2, which contributes to excitatory-to-inhibitory GABA polarity switch in developing neurons. We also revealed the altered expression pattern of KCC2 in hiPSC-derived neurons from the patient with schizophrenia, which could contribute to understanding the pathology of schizophrenia in the developing nervous system.


Subject(s)
GABAergic Neurons/metabolism , Induced Pluripotent Stem Cells/metabolism , Neurons/metabolism , Schizophrenia/metabolism , Symporters/biosynthesis , Twins, Monozygotic , Cell Differentiation/physiology , Cells, Cultured , Excitatory Postsynaptic Potentials/physiology , Fibroblasts/metabolism , Fibroblasts/pathology , GABAergic Neurons/pathology , Humans , Induced Pluripotent Stem Cells/pathology , Male , Neural Inhibition/physiology , Neurons/pathology , Schizophrenia/genetics , Schizophrenia/pathology , Symporters/genetics , Twins, Monozygotic/genetics , Young Adult
3.
Sci Rep ; 7(1): 5481, 2017 07 14.
Article in English | MEDLINE | ID: mdl-28710465

ABSTRACT

Social isolation is an important factor in the development of psychiatric disorders. It is necessary to develop an effective psychological treatment, such as cognitive rehabilitation, for children who have already suffered from social isolation, such as neglect and social rejection. We used socially isolated mice to validate whether elaborate re-socialization after juvenile social isolation can restore hypomyelination in the medial prefrontal cortex (mPFC) and the attendant functions manifested in socially isolated mice. While mice who underwent re-socialization with socially isolated mice after juvenile social isolation (Re-IS mice) demonstrated less mPFC activity during exposure to a strange mouse, as well as thinner myelin in the mPFC than controls, mice who underwent re-socialization with socially housed mice after juvenile social isolation (Re-SH mice) caught up with the controls in terms of most mPFC functions, as well as myelination. Moreover, social interaction of Re-IS mice was reduced as compared to controls, but Re-SH mice showed an amount of social interaction comparable to that of controls. These results suggest that the mode of re-socialization after juvenile social isolation has significant effects on myelination in the mPFC and the attendant functions in mice, indicating the importance of appropriate psychosocial intervention after social isolation.


Subject(s)
Myelin Sheath/physiology , Prefrontal Cortex/physiology , Social Isolation , Socialization , Animals , Male , Mice, Inbred C57BL , Myelin Sheath/ultrastructure , Prefrontal Cortex/ultrastructure , Social Behavior
4.
Brain Behav Immun ; 61: 375-385, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28089559

ABSTRACT

Several studies have revealed that neuregulins (NRGs) are involved in brain function and psychiatric disorders. While NRGs have been regarded as neuron- or astrocyte-derived molecules, our research has revealed that microglia also express NRGs, levels of which are markedly increased in activated microglia. Previous studies have indicated that microglia are activated in the brains of individuals with autism spectrum disorder (ASD). Therefore, we investigated microglial NRG mRNA expression in multiple lines of mice considered models of ASD. Intriguingly, microglial NRG expression significantly increased in BTBR and socially-isolated mice, while maternal immune activation (MIA) mice exhibited identical NRG expression to controls. Furthermore, we observed a positive correlation between NRG expression in microglia and peripheral blood mononuclear cells (PBMCs) in mice, suggesting that NRG expression in human PBMCs may mirror microglia-derived NRG expression in the human brain. To translate these findings for application in clinical psychiatry, we measured levels of NRG1 splice-variant expression in clinically available PBMCs of patients with ASD. Levels of NRG1 type III expression in PBMCs were positively correlated with impairments in social interaction in children with ASD (as assessed using the Autistic Diagnostic Interview-Revised test: ADI-R). These findings suggest that immune cell-derived NRGs may be implicated in the pathobiology of psychiatric disorders such as ASD.


Subject(s)
Autism Spectrum Disorder/metabolism , Interpersonal Relations , Microglia/metabolism , Neuregulin-1/metabolism , Adolescent , Animals , Autism Spectrum Disorder/genetics , Brain/metabolism , Child , Disease Models, Animal , Humans , Leukocytes, Mononuclear/metabolism , Male , Mice , Neuregulin-1/genetics , Neurons/metabolism , Social Isolation
5.
FASEB J ; 30(12): 4267-4274, 2016 12.
Article in English | MEDLINE | ID: mdl-27613805

ABSTRACT

Recent studies have revealed that social experience affects myelination. These findings have important implications for disorders that feature abnormal myelination, such as multiple sclerosis (MS), as previous studies have shown that psychosocial stress exacerbates the pathobiology of MS. However, most studies have focused on psychosocial stress during the demyelination phase of MS and have not investigated the effects of social experience on remyelination. Thus, the current study sought to determine whether social experience can alter remyelination after myelin depletion. Myelin in the mouse medial prefrontal cortex was depleted with cuprizone, and the effects of subsequent social isolation on remyelination were evaluated. Remyelination was severely impaired in socially isolated mice. Social isolation also increased IL-6 levels in the medial prefrontal cortex, and administration of an IL-6 inhibitor (ND50 = 0.01-0.03 µg for 0.25 ng/ml IL-6) ameliorated remyelination impairments. Consistent with this result, IL-6 administration (ED50 = 0.02-0.06 ng/ml) disturbed remyelination. In addition, neuron-oligodendrocyte coculture experiments showed that IL-6 treatment (ED50 ≤ 0.02 ng/ml) markedly impeded myelination, which was recovered with IL-6 inhibitor administration (ND50 = 0.01-0.03 µg for 0.25 ng/ml IL-6). This study provides the first direct evidence, to our knowledge, that social experience influences remyelination via modulation of IL-6 expression. These findings indicate that psychosocial stress may disturb remyelination through regulation of IL-6 expression in patients with such demyelinating diseases that involve remyelination as MS.-Makinodan, M., Ikawa, D., Miyamoto, Y., Yamauchi, J., Yamamuro, K., Yamashita, Y., Toritsuka, M., Kimoto, S., Okumura, K., Yamauchi, T., Fukami, S., Yoshino, H., Wanaka, A., Kishimoto, T. Social isolation impairs remyelination in mice through modulation of IL-6.


Subject(s)
Demyelinating Diseases/metabolism , Interleukin-6/metabolism , Myelin Sheath/metabolism , Oligodendroglia/drug effects , Social Isolation , Animals , Cuprizone/pharmacology , Male , Mice, Inbred C57BL , Multiple Sclerosis/metabolism , Oligodendroglia/metabolism , Regeneration/drug effects
6.
Cell Biochem Funct ; 32(4): 395-400, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24888443

ABSTRACT

Central pontine myelinolysis is one of the idiopathic or iatrogenic brain dysfunction, and the most common cause is excessively rapid correction of chronic hyponatraemia. While myelin disruption is the main pathology, as the diagnostic name indicates, a previous study has reported that astrocyte death precedes the destruction of the myelin sheath after the rapid correction of chronic low Na(+) levels, and interestingly, certain brain regions (cerebral cortex, hippocampus, etc.) are specifically damaged but not cerebellum. Here, using primary astrocyte cultures derived from rat cerebral cortex and cerebellum, we examined how extracellular Na(+) alterations affect astrocyte death and whether the response is different between the two populations of astrocytes. Twice the amount of extracellular [Na(+) ] and voltage-gated Na(+) channel opening induced substantial apoptosis in both populations of astrocytes, while, in contrast, one half [Na(+) ] prevented apoptosis in cerebellar astrocytes, in which the Na(+) -Ca(2+) exchanger, NCX2, was highly expressed but not in cerebral astrocytes. Strikingly, the rapid correction of chronic one half [Na(+) ] exposure significantly increased apoptosis in cerebellar astrocytes but not in cerebral astrocytes. These results indicate that extracellular [Na(+) ] affects astrocyte apoptosis, and the response to alterations in [Na(+) ] is dependent on the brain region from which the astrocyte is derived.


Subject(s)
Apoptosis/physiology , Astrocytes/metabolism , Cerebellum/metabolism , Cerebral Cortex/metabolism , Extracellular Space/metabolism , Sodium/metabolism , Animals , Cells, Cultured , Cerebellum/cytology , Cerebral Cortex/cytology , Embryo, Mammalian/cytology , Primary Cell Culture , Rats, Wistar
7.
Mol Brain ; 4: 14, 2011 Apr 13.
Article in English | MEDLINE | ID: mdl-21486496

ABSTRACT

BACKGROUND: The specific genetic regulation of neural primordial cell determination is of great interest in stem cell biology. The Musashi1 (Msi1) protein, which belongs to an evolutionarily conserved family of RNA-binding proteins, is a marker for neural stem/progenitor cells (NS/PCs) in the embryonic and post-natal central nervous system (CNS). Msi1 regulates the translation of its downstream targets, including m-Numb and p21 mRNAs. In vitro experiments using knockout mice have shown that Msi1 and its isoform Musashi2 (Msi2) keep NS/PCs in an undifferentiated and proliferative state. Msi1 is expressed not only in NS/PCs, but also in other somatic stem cells and in tumours. Based on previous findings, Msi1 is likely to be a key regulator for maintaining the characteristics of self-renewing stem cells. However, the mechanisms regulating Msi1 expression are not yet clear. RESULTS: To identify the DNA region affecting Msi1 transcription, we inserted the fusion gene ffLuc, comprised of the fluorescent Venus protein and firefly Luciferase, at the translation initiation site of the mouse Msi1 gene locus contained in a 184-kb bacterial artificial chromosome (BAC). Fluorescence and Luciferase activity, reflecting the Msi1 transcriptional activity, were observed in a stable BAC-carrying embryonic stem cell line when it was induced toward neural lineage differentiation by retinoic acid treatment. When neuronal differentiation was induced in embryoid body (EB)-derived neurosphere cells, reporter signals were detected in Msi1-positive NSCs and GFAP-positive astrocytes, but not in MAP2-positive neurons. By introducing deletions into the BAC reporter gene and conducting further reporter experiments using a minimized enhancer region, we identified a region, "D5E2," that is responsible for Msi1 transcription in NS/PCs. CONCLUSIONS: A regulatory element for Msi1 transcription in NS/PCs is located in the sixth intron of the Msi1 gene. The 595-bp D5E2 intronic enhancer can transactivate Msi1 gene expression with cell-type specificity markedly similar to the endogenous Msi1 expression patterns.


Subject(s)
Enhancer Elements, Genetic/genetics , Gene Expression Regulation , Introns/genetics , Nerve Tissue Proteins/genetics , Neural Stem Cells/metabolism , RNA-Binding Proteins/genetics , Transcription, Genetic , Animals , Astrocytes/cytology , Astrocytes/metabolism , Base Pairing/genetics , Cell Line , Chromosomes, Artificial, Bacterial/genetics , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Exons/genetics , Genes, Reporter , Genome/genetics , Luciferases/metabolism , Mice , Mice, Transgenic , Nerve Tissue Proteins/metabolism , Neural Stem Cells/cytology , Neurogenesis/genetics , Neuroglia/metabolism , Organ Specificity/genetics , RNA-Binding Proteins/metabolism , Sequence Deletion , Transcriptional Activation/genetics
8.
Stem Cells ; 28(9): 1661-73, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20652960

ABSTRACT

Fibroblast growth factor (FGF) is among the most common growth factors used in cultures to maintain self-renewal and proliferative capabilities of a variety of stem cells, including neural stem cells (NSCs). However, the molecular mechanisms underlying the control by FGF have remained elusive. Studies on mutant mice of FGF receptor substrate 2α (FRS2α), a central mediator for FGF signaling, combined with FRS2α knockdown or gain-of-function experiments, allowed us to dissect the role of FGF signaling for the self-renewal and proliferation of NSCs and to provide novel molecular mechanisms for them. We identified Hes1 as a novel self-renewal target of FGF-signaling. Quantitatively different levels of Erk activation mediated by FRS2α may regulate self-renewal of NSCs and proliferation of neural stem/progenitor cells (NSPCs); low levels of Erk activation are sufficient for the former, however, higher levels are required for maximum activity of the latter. Thus, FRS2α fine-tunes the FGF-signaling to control qualitatively different biological activities, self-renewal at least partly through Hes1 versus proliferation of NSPCs.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Cell Proliferation , Extracellular Signal-Regulated MAP Kinases/metabolism , Fibroblast Growth Factor 2/metabolism , Homeodomain Proteins/metabolism , Membrane Proteins/metabolism , Neurons/enzymology , Signal Transduction , Stem Cells/enzymology , Telencephalon/enzymology , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Binding Sites , Cell Differentiation , Cell Proliferation/drug effects , Enzyme Activation , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , GRB2 Adaptor Protein/metabolism , Homeodomain Proteins/genetics , Membrane Proteins/genetics , Mice , Mice, Inbred ICR , Mice, Transgenic , Mutation , Neurons/drug effects , Protein Kinase Inhibitors/pharmacology , RNA Interference , Signal Transduction/drug effects , Spheroids, Cellular , Stem Cells/drug effects , Telencephalon/drug effects , Telencephalon/embryology , Time Factors , Transcription Factor HES-1 , Transfection
9.
Stem Cells ; 25(6): 1410-22, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17332510

ABSTRACT

Gab1 (Grb2 associated binder1) has been identified as an adaptor molecule downstream of many growth factors, including epidermal growth factor (EGF), fibroblast growth factor, and platelet-derived growth factor, which have been shown to play crucial roles as mitotic signals for a variety of neural progenitor cells, including stem cells, both in vitro and in vivo. Here, we show that Gab1 deficiency results in a reduction in the number of Olig2-positive (Olig2(+)) progenitor cells in the developing mouse spinal cord after embryonic day 12.5 (E12.5), when gliogenesis starts in the pMN domain where the EGF receptor (EGFR) is expressed predominantly. Our in vitro analysis further revealed that Gab1 is essential for EGF-dependent proliferation of Olig2(+) progenitor cells derived from the E12.5 ventral and E14.5 dorsal but not ventral spinal cord, whereas Gab1 is always required for the activation of Akt1 but not of ERK1/2. Moreover, we found that the action of the Gab1/Akt pathway is context-dependent, since constitutively active Akt1 could rescue the proliferation defect only in the E12.5 spinal cord of the Gab1-deficient mouse in vitro. Finally, we demonstrated that EGFR-deficient mice and Gab1-deficient mice showed a similar reduction in the number of Olig2(+) progenitor cells in the developing spinal cord. These findings indicate that EGFR-mediated signaling through Gab1/Akt contributes to the sufficient expansion of Olig2(+) progenitor cells in a spatiotemporally regulated manner, which represents the origin of glial cells in the developing spinal cord. Disclosure of potential conflicts of interest is found at the end of this article.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Cell Proliferation/drug effects , Epidermal Growth Factor/metabolism , Nerve Tissue Proteins/metabolism , Phosphoproteins/physiology , Spinal Cord/embryology , Stem Cells/cytology , Adaptor Proteins, Signal Transducing , Animals , Cell Count , Cells, Cultured , Epidermal Growth Factor/physiology , Gene Expression Regulation, Developmental , Genes, erbB-1/physiology , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Mice, Knockout , Neurons/cytology , Oligodendrocyte Transcription Factor 2 , Oncogene Protein v-akt/physiology , Phosphoproteins/genetics , Signal Transduction/drug effects , Signal Transduction/physiology , Spinal Cord/drug effects , Spinal Cord/metabolism , Stem Cells/drug effects , Stem Cells/metabolism
10.
Nat Biotechnol ; 23(5): 607-11, 2005 May.
Article in English | MEDLINE | ID: mdl-15867910

ABSTRACT

Embryonic stem (ES) cells are a promising source of cardiomyocytes, but clinical application of ES cells has been hindered by the lack of reliable selective differentiation methods. Differentiation into any lineage is partly dependent on the regulatory mechanisms of normal early development. Although several signals, including bone morphogenetic protein (BMP), Wnt and FGF, are involved in heart development, scarce evidence is available about the exact signals that mediate cardiomyocyte differentiation. While investigating the involvement of BMP signaling in early heart formation in the mouse, we found that the BMP antagonist Noggin is transiently but strongly expressed in the heart-forming region during gastrulation and acts at the level of induction of mesendoderm to establish conditions conducive to cardiogenesis. We applied this finding to develop an effective protocol for obtaining cardiomyocytes from mouse ES cells by inhibition of BMP signaling.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Carrier Proteins/metabolism , Myocytes, Cardiac/cytology , Myocytes, Cardiac/physiology , Signal Transduction/physiology , Stem Cells/cytology , Stem Cells/physiology , Animals , Carrier Proteins/administration & dosage , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Mice , Mice, Inbred ICR , Myocytes, Cardiac/drug effects , Signal Transduction/drug effects , Stem Cells/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...